Connection

SUSAN BLANEY to Proteasome Inhibitors

This is a "connection" page, showing publications SUSAN BLANEY has written about Proteasome Inhibitors.
Connection Strength

0.237
  1. Phase I study of the proteasome inhibitor bortezomib in pediatric patients with refractory solid tumors: a Children's Oncology Group study (ADVL0015). J Clin Oncol. 2004 Dec 01; 22(23):4804-9.
    View in: PubMed
    Score: 0.237
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.